Showing results (271-280 of 283) with videos related to
Sort By:
Pageof 29
Blood|February 15, 1989
Immunohistochemical detection and quantitation of P-glycoprotein in multiple drug-resistant human myeloma cells: association with level of drug resistance and drug accumulationW S Dalton, T M Grogan, J A Rybski, et al.The New England Journal of Medicine|January 5, 2002
Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancerR C Flanigan, S E Salmon, B A Blumenstein, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1986
Improved survival duration with combination chemotherapy induction for multiple myeloma: a Southwest Oncology Group StudyB G Durie, D O Dixon, S Carter, et al.Cancer Genetics and Cytogenetics|September 1, 1995
Cytogenetics of 158 patients with regional or disseminated melanoma. Subset analysis of near-diploid and simple karyotypesF H Thompson, J Emerson, S Olson, et al.Cancer|May 1, 1977
Dose response evaluation of adriamycin in human neoplasiaR M O'Bryan, L H Baker, J E Gottlieb, et al.NCI Monographs : a Publication of the National Cancer Institute|January 1, 1986
Adjuvant chemotherapy of axillary node-negative carcinoma of the breast using doxorubicin and cyclophosphamideR J Brooks, S E Jones, S E Salmon, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
Phase I pharmacokinetic trial and correlative in vitro phase II tumor kinetic study of Apomine (SR-45023A), a novel oral biphosphonate anticancer drugD S Alberts, A V Hallum, M Stratton-Custis, et al.Cancer|January 1, 1991
A Southwest Oncology Group study on the use of a human tumor cloning assay for predicting response in patients with ovarian cancerD D Von Hoff, R Kronmal, S E Salmon, et al.Cancer Research|May 1, 1985
Application of a human tumor colony-forming assay to new drug screeningR H Shoemaker, M K Wolpert-DeFilippes, D H Kern, et al.Cancer|March 15, 1983
Improved complete remission rates and survival for patients with large cell lymphoma treated with chemoimmunotherapy. A Southwest Oncology Group StudyS E Jones, P N Grozea, E N Metz, et al.Pageof 29